Agilent Technologies

Agilent Technologies (A) is a publicly traded company in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

The company reports trailing twelve-month revenue of $4.47B and net income of $305.00M.

Key metrics include a return on equity of 4.4%, a debt-to-equity ratio of 0.85.

Investors tracking A can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.